These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18280832)

  • 1. Efficacy of conservative therapy as taught in the primary care setting for symptoms suggesting infant gastroesophageal reflux.
    Orenstein SR; McGowan JD
    J Pediatr; 2008 Mar; 152(3):310-4. PubMed ID: 18280832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The infant gastroesophageal reflux questionnaire revised: development and validation as an evaluative instrument.
    Kleinman L; Rothman M; Strauss R; Orenstein SR; Nelson S; Vandenplas Y; Cucchiara S; Revicki DA
    Clin Gastroenterol Hepatol; 2006 May; 4(5):588-96. PubMed ID: 16678075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is gastroesophageal reflux disease really a life-long disease: do babies who regurgitate grow up to be adults with GERD complications?
    Gold BD
    Am J Gastroenterol; 2006 Mar; 101(3):641-4. PubMed ID: 16542297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical response to 2 dosing regimens of lansoprazole in infants with gastroesophageal reflux.
    Khoshoo V; Dhume P
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):352-4. PubMed ID: 18376260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?
    Beaumont H; Boeckxstaens GE
    Am J Gastroenterol; 2009 Jul; 104(7):1764-71. PubMed ID: 19491837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant enhancement of esophageal pre-epithelial defense by tegaserod: implications for an esophagoprotective effect.
    Majewski M; Jaworski T; Sarosiek I; Sostarich S; Roeser K; Edlavitch SA; Kralstein J; Wallner G; McCallum RW; Sarosiek J
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):430-8. PubMed ID: 17445751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance to H2 receptor antagonist correlates well with the decline in efficacy against gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Furuta K; Adachi K; Komazawa Y; Mihara T; Miki M; Azumi T; Fujisawa T; Katsube T; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1581-5. PubMed ID: 16928220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroesophageal reflux disease in children: association between symptoms and pH monitoring.
    Størdal K; Johannesdottir GB; Bentsen BS; Sandvik L
    Scand J Gastroenterol; 2005 Jun; 40(6):636-40. PubMed ID: 16036522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
    Omari TI; Haslam RR; Lundborg P; Davidson GP
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):41-4. PubMed ID: 17204951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoluminal gastroplication for the treatment of gastroesophageal reflux disease: a 2-year prospective pilot study from Taiwan.
    Liao CC; Lee CL; Lin BR; Bai CH; Hsieh YH; Wu CH; Gostout CJ
    J Gastroenterol Hepatol; 2008 Mar; 23(3):398-405. PubMed ID: 18318824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of the Reflux Disease Questionnaire in general practice.
    Aanen MC; Numans ME; Weusten BL; Smout AJ
    Digestion; 2006; 74(3-4):162-8. PubMed ID: 17351321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and natural history of gastroesophageal reflux: pediatric prospective survey.
    Campanozzi A; Boccia G; Pensabene L; Panetta F; Marseglia A; Strisciuglio P; Barbera C; Magazzù G; Pettoello-Mantovani M; Staiano A
    Pediatrics; 2009 Mar; 123(3):779-83. PubMed ID: 19255002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.
    Orenstein SR; Hassall E; Furmaga-Jablonska W; Atkinson S; Raanan M
    J Pediatr; 2009 Apr; 154(4):514-520.e4. PubMed ID: 19054529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In support of "step-up therapy" for gastroesophageal reflux disease.
    Beck IT
    Am J Gastroenterol; 2002 Feb; 97(2):503-4. PubMed ID: 11866309
    [No Abstract]   [Full Text] [Related]  

  • 16. Acid gastroesophageal reflux and intensity of symptoms in children with gastroesophageal reflux disease. Comparison of primary gastroesophageal reflux and gastroesophageal reflux secondary to food allergy.
    Semeniuk J; Kaczmarski M
    Adv Med Sci; 2008; 53(2):293-9. PubMed ID: 19095581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary report on the efficacy of the Multicare AR-Bed in 3-week-3-month-old infants on regurgitation, associated symptoms and acid reflux.
    Vandenplas Y; De Schepper J; Verheyden S; Devreker T; Franckx J; Peelman M; Denayer E; Hauser B
    Arch Dis Child; 2010 Jan; 95(1):26-30. PubMed ID: 19700421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical predictors of pathological gastro-oesophageal reflux in infants with persistent distress.
    Heine RG; Jordan B; Lubitz L; Meehan M; Catto-Smith AG
    J Paediatr Child Health; 2006 Mar; 42(3):134-9. PubMed ID: 16509914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manometric study of lower esophageal sphincter in children with primary acid gastroesophageal reflux and acid gastroesophageal reflux secondary to food allergy.
    Semeniuk J; Kaczmarski M; Uścinowicz M
    Adv Med Sci; 2008; 53(2):283-92. PubMed ID: 18842562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of delayed release rabeprazole in 1- to 11-month-old infants with symptomatic GERD.
    Hussain S; Kierkus J; Hu P; Hoffman D; Lekich R; Sloan S; Treem W
    J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):226-36. PubMed ID: 24121146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.